Molecular epidemiology of HIV type 1 in Mexico: Emergence of BG and BF intersubtype recombinants

AIDS Research and Human Retroviruses

Volumn 26, Issue 7, 2010, Pages 777-781

  Vázquez Valls, Eduardo ^a   Escoto Delgadillo, Martha ^b   López Márquez, Francisco Carlos ^c   Castillero Manzano, Marcelo ^a   Echegaray Guerrero, Ernesto ^a   Bitzer Quintero, Oscar Kurt ^a   Kobayashi Gutiérrez, Antonio ^d   Torres Mendoza, Blanca Miriam ^a,b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c Departamento de Inmunobiología Molecular Del Centro de Investigación Biomédica De la Facultad de Medicina de la Universidad Autónoma de Torreón   (Mexico)

^d HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; POL PROTEIN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; MEXICO; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; VIRUS LOAD; VIRUS RECOMBINATION; AGED; CLASSIFICATION; CLUSTER ANALYSIS; DNA SEQUENCE; GENETIC RECOMBINATION; GENETICS; GENOTYPE; HIV INFECTIONS; ISOLATION AND PURIFICATION; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR GENETICS; SEQUENCE HOMOLOGY; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CLUSTER ANALYSIS; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MEXICO; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; PHYLOGENY; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY;

EID: 77954897634     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0195     Document Type: Article

References (27)

1. Ramirez BC, Simon-Loriere E, Galetto R, and Negroni M: Implications of recombination for HIV diversity. Virus Res 2008;134(1-2):64-73.
2. Chin MP, Rhodes TD, Chen J, Fu W, and Hu WS: Identification of a major restriction in HIV-1 intersubtype recombination. Proc Natl Acad Sci USA 2005;102(25):9002-9007.
3. Lynch RM, Shen T, Gnanakaran S, and Derdeyn CA: Appreciating HIV type 1 diversity: Subtype differences in env. AIDS Res Hum Retroviruses 2009;25(3):237-248.
4. Taylor BS, Sobieszczyk ME, McCutchan FE, and Hammer SM: The challenge of HIV-1 subtype diversity. N Engl J Med 2008;358(15):1590-1602.
5. Hemelaar J, Gouws E, Ghys PD, and Osmanov S: Global and regional distribution of HIV-1 genetic subtypes and recom-binants in 2004. AIDS 2006;20(16):W13-W23.
6. Kantor R: Impact of HIV-1 pol diversity on drug resistance and its clinical implications. Curr Opin Infect Dis 2006; 19(6):594-606.
7. McCutchan FE: Global epidemiology of HIV. J Med Virol 2006;78(Suppl 1):S7-S12.
8. a. ed. Mexico, 2008. (Accessed November 2, 2009, at http://www.censida.salud.gob.mx/interior/guias manuales.html.)
9. Censida: Casos de SIDA en México, 2009. (Accessed November 2, 2009, at http://www.censida.salud.gob.mx.)
10. Vázquez-Valls E, Escoto-Delagadillo M, and Torres-Mendoza BM: Intersubtype recombinant HIV-1 subtype B and drug resistance mutation in Mexican patients. XVI International AIDS Conference, Toronto, Canada, August 13-18 2006. Abstract No. B25.
11. Rivera-Morales LG, Novitsky VA, Trujillo JR, et al.: The molecular epidemiology of HIV type 1 of men in Mexico. AIDS Res Hum Retroviruses 2001;17(1):87-92.
12. Sacktor N, Nakasujja N, Skolasky RL, et al.: HIV subtype D is associated with dementia, compared with subtype A, in im-munosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis 2009;49(5):780-786.
13. Mcbride MJ: Migrants and asylum seekers: Policy responses in the United States to immigrants and refugees from Central America and the Caribbean. Int Migr 1999;37(1):289-317.
14. Kumar S, Tamura K, and Nei M: MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 2004;5(2):150-163.
15. Lole KS, Bollinger RC, Paranjape RS, et al.: Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of inter-subtype recombination. J Virol 1999;73(1):152-160.
16. Rousseau CM, Learn GH, Bhattacharya T, et al.: Extensive intrasubtype recombination in South African human immunodeficiency virus type 1 subtype C infections. J Virol 2007;81(9):4492-4500.
17. Korber B, Muldoon M, Theiler J, et al.: Timing the ancestor of the HIV-1 pandemic strains. Science 2000;288(5472):1789-1796.
18. Petroni A, Deluchi G, Pryluka D, et al.: Update on primary HIV-1 resistance in Argentina: Emergence of mutations conferring high-level resistance to nonnucleoside reverse transcriptase inhibitors in drug-naive patients. J Acquir Immune Defic Syndr 2006;42(4):506-510.
19. Thomson MM, Delgado E, Herrero I, et al.: Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences. J Gen Virol 2002;83(Pt 1):107-119.
20. Brennan CA, Brites C, Bodelle P, et al.: HIV-1 strains identified in Brazilian blood donors: Significant prevalence of B/F1 recombinants. AIDS Res Hum Retroviruses 2007; 23(11):1434-1441.
21. de Souza AC, de Oliveira CM, Rodrigues CL, Silva SA, and Levi JE: Molecular characterization of HIV type 1 BF pol recombinants from São Paulo, Brazil. AIDS Res Hum Ret-roviruses 2008;24(12):1521-1525.
22. Ŕos M, Delgado E, Pérez-Alvarez L, et al.: Antiretroviral drug resistance and phylogenetic diversity of HIV-1 in Chile. J Med Virol 2007;79(6):647-656.
23. Sierra M, Thomson MM, Posada D, et al.: Identification of 3 phylogenetically related HIV-1 BG intersubtype circulating recombinant forms in Cuba. J Acquir Immune Defic Syndr 2007;45(2):151-160.
24. Pérez-Alvarez L, Muñoz M, Delgado E, et al.: Spanish Group for Antiretroviral Resistance Studies in Galicia. Isolation and biological characterization of HIV-1 BG intersubtype re-combinants and other genetic forms circulating in Galicia, Spain. J Med Virol 2006;78(12):1520-1528.
25. Delgado E, Thomson MM, Villahermosa ML, et al.: Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure. J Acquir Immune Defic Syndr 2002;29(5):536-543.
26. Aragonés C, González Z, Pérez J, Casado G, and Nájera R: Identification of 3 phylogenetically related HIV-1 BG inter-subtype circulating recombinant forms in Cuba. J Acquir Immune Defic Syndr 2007;45(2):151-160.
27. Agwale SM, Shata MT, Reitz MS Jr, et al.: A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice. Proc Natl Acad Sci USA 2002; 99(15):10037-10041.